UBS Group
KURE icon

UBS Group’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

UBS Group’s Portfolio KURE Stock Details KURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Sell
58,867
-43,352
-42% -$768K ﹤0.01% 5555
2025
Q4 		$1.74M Buy
102,219
+85,487
+511% +$1.63M ﹤0.01% 5094
2025
Q3 		$350K Buy
16,732
+11,705
+233% +$230K ﹤0.01% 6337
2025
Q2 		$85.1K Sell
5,027
-1,685
-25% -$26.8K ﹤0.01% 7365
2025
Q1 		$105K Buy
6,712
+5,859
+687% +$85.8K ﹤0.01% 7019
2024
Q4 		$12.1K Sell
853
-947
-53% -$14.7K ﹤0.01% 8215
2024
Q3 		$30.1K Sell
1,800
-1,226
-41% -$16.7K ﹤0.01% 7128
2024
Q2 		$40K Buy
3,026
+1,133
+60% +$16.3K ﹤0.01% 6863
2024
Q1 		$27.5K Buy
1,893
+114
+6% +$1.76K ﹤0.01% 6771
2023
Q4 		$31.1K Buy
1,779
+238
+15% +$4.25K ﹤0.01% 6823
2023
Q3 		$27.4K Sell
1,541
-100
-6% -$1.78K ﹤0.01% 6635
2023
Q2 		$29.6K Buy
+1,641
New +$32.7K ﹤0.01% 6724
2023
Q1 		– Sell
-1,789
Closed -$38.3K – 10001
2022
Q4 		$38.3K Sell
1,789
-5,717
-76% -$112K ﹤0.01% 7012
2022
Q3 		$133K Buy
7,506
+2,500
+50% +$52.1K ﹤0.01% 5459
2022
Q2 		$117K Buy
5,006
+443
+10% +$9.32K ﹤0.01% 5303
2022
Q1 		$106K Sell
4,563
-106,195
-96% -$2.61M ﹤0.01% 5874
2021
Q4 		$3.18M Sell
110,758
-3,159
-3% -$109K ﹤0.01% 3301
2021
Q3 		$4.26M Buy
113,917
+26,936
+31% +$1.05M ﹤0.01% 2841
2021
Q2 		$3.96M Buy
86,981
+13,794
+19% +$587K ﹤0.01% 2923
2021
Q1 		$2.85M Buy
73,187
+14,011
+24% +$573K ﹤0.01% 3199
2020
Q4 		$2.31M Sell
59,176
-8,231
-12% -$291K ﹤0.01% 3281
2020
Q3 		$2.26M Buy
67,407
+3,372
+5% +$115K ﹤0.01% 2935
2020
Q2 		$2.04M Sell
64,035
-63,140
-50% -$1.73M ﹤0.01% 2861
2020
Q1 		$3.02M Buy
127,175
+123,266
+3,153% +$3M ﹤0.01% 2372
2019
Q4 		$91K Sell
3,909
-2,643
-40% -$60.1K ﹤0.01% 6052
2019
Q3 		$138K Buy
6,552
+4,557
+228% +$95.2K ﹤0.01% 5547
2019
Q2 		$41K Buy
1,995
+815
+69% +$17.1K ﹤0.01% 6087
2019
Q1 		$26K Sell
1,180
-1,649
-58% -$32.7K ﹤0.01% 6064
2018
Q4 		$48K Buy
2,829
+1,452
+105% +$29K ﹤0.01% 6120
2018
Q3 		$31K Buy
1,377
+371
+37% +$8.96K ﹤0.01% 6508
2018
Q2 		$27K Buy
+1,006
New +$28.3K ﹤0.01% 6473

Other funds holding KURE

VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return

UBS Group's KURE Position: Q1 2026 in Review

UBS Group reduced its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 42% in Q1 2026, selling an estimated $768K and leaving 58,867 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #5555.

UBS Group first reported a position in KURE in Q2 2018 and has held it in 31 quarters since. The position peaked at $4.26M in Q3 2021. 16 funds tracked by Wall St. Rank hold KURE as of Q1 2026.

  • UBS Group held 58,867 shares of KraneShares MSCI All China Health Care Index ETF worth $1M as of Q1 2026.
  • UBS Group sold 43,352 KraneShares MSCI All China Health Care Index ETF shares in Q1 2026, an estimated $768K.
  • KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5555 holding.
  • UBS Group first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2018 and has held it in 31 quarters since.
  • UBS Group's KraneShares MSCI All China Health Care Index ETF position peaked at $4.26M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.